Completed EUCTR 2005-001233-16
This study is completed in Czechia. It focuses on manic episodes in bipolarity type I.
In Czech Republic Bipolarity Other
Countries Czechia
Sponsor Bristol-Myers Squibb International Corporation
Condition Bipolarity Completed EUCTR 2004-000202-49
This study is completed in Estonia, in Hungary, in Spain, .... It focuses on manic episodes in bipolarity type I.
In Estonia Bipolarity Other
Countries Estonia, Hungary, Spain, ...
Sponsor Bristol-Myers Squibb International Corporation
Condition Bipolarity Withdrawn NCT01207622
This summary needs review. Please check the official study record and contact the research team for details.
In Cambridge ADHD, Addiction Drug i A study involving a medication or substance. From 15 Years to 30 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition ADHD, Addiction Completed NCT00529893
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
In Taipei ADHD Other From 10 Years to 15 Years
Countries Taiwan
Sponsor National Taiwan University Hospital
Condition ADHD Completed NCT00320528
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Acireale ADHD Drug From 6 Years to 15 Years
Countries Italy
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT00525252
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Addiction Drug From 18 Years to 75 Years
Countries
Sponsor Catholic University of the Sacred Heart
Condition Addiction Completed EUCTR 2007-007020-18
This study is completed in Italy. It focuses on Addiction.
In Italy Addiction Other
Countries Italy
Sponsor POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Condition Addiction Terminated NCT00658645
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Radnevo Schizophrenia Drug From 18 Years to 65 Years
Countries Bulgaria, China, Greece, ...
Sponsor H. Lundbeck A/S
Condition Schizophrenia Completed NCT06510504
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Encino Anxiety Drug From 18 Years to 65 Years
Countries United States
Sponsor Bionomics Limited
Condition Anxiety Completed NCT01270555
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed ADHD, Addiction Drug From 18 Years to 60 Years
Countries
Sponsor Massachusetts General Hospital
Condition ADHD, Addiction Completed NCT04503954
This summary needs review. Please check the official study record and contact the research team for details.
In Taipei Schizophrenia Behavioral From 20 Years to 99 Years
Countries Taiwan
Sponsor National Taipei University of Nursing and Health Sciences
Condition Schizophrenia Completed NCT02095496
This summary needs review. Please check the official study record and contact the research team for details.
In Brussels Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 94 Years
Countries Belgium
Sponsor Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Condition Schizophrenia